Evidence meets everyday living.
Clinical perspectives on GLP-1 & weight loss, oncology nutrition, food policy, and lifestyle medicine. Written from the clinical bedside, grounded in peer-reviewed evidence.
Most clinical writing online is either too dilute to inform a decision or too dense to read on a Tuesday night between meetings. The work here tries to live in the middle: substantive enough that a practicing clinician can use it at the bedside, accessible enough that a patient or executive can read it without a glossary.
Each piece is grounded in peer-reviewed evidence — typically Phase 2/3 trial data, meta-analyses, and the clinical guidelines that flow from them. Where the evidence is contested or incomplete, that gets said explicitly. Where industry marketing has filled gaps the science hasn't yet, that gets said too. The bias here is toward the conservative, “what would I tell my own patient” interpretation — not the maximum-engagement headline.
Four content pillars: GLP-1 & weight loss (the muscle-preservation problem, dosing-day nutrition, plateau strategy, off-cycle planning), oncology nutrition (the most underappreciated quality-of-life lever in active treatment, and where my clinical career began), food and healthcare policy (where workforce structures, supplemental programs, and reimbursement collide with bedside reality), and lifestyle medicine (the boring, evidence-rich interventions that don't get marketing budgets).
Intended for practicing clinicians, allied health professionals, patients navigating complex treatment, healthcare-system leadership trying to make better workforce decisions, and the curious public who'd rather read the underlying data than the headline. Every article cites its primary sources inline so you can follow the trail.
New analyses are published during active research cycles. Topic suggestions, source corrections, and clinical disagreement all welcome at [email protected].
Why I Order Your Labs — And Why DTC Lab Kits Miss the Point
The direct-to-consumer lab market hit $3B in 2024. Here's why clinician-ordered panels remain the standard of care in premium clinical nutrition — and exactly what generic panels miss in real practice.
The 2× Protein Rule: Why GLP-1 Patients Need Double the Standard Recommendation
The standard 0.8 g/kg protein recommendation was designed to prevent deficiency, not preserve muscle during rapid GLP-1 weight loss. A clinical breakdown of the evidence-based 2× rule and exactly how to hit it when appetite is suppressed — with two interactive charts.
The Missing Screw: Why Healthcare Gets Rebuilt Every 5 Years While Patients Age Over 50
Healthcare is being designed by people who will never feel the consequences of their designs. An essay on executive short-termism, the hollowing of the clinical workforce, and the load-bearing services quietly optimized away — with five source-cited charts.
Why 25–39% of Your GLP-1 Weight Loss May Be Muscle — And Exactly How to Stop It
Tirzepatide produces remarkable weight loss, but one-third of it is muscle. The resistance training prescription and protein-timing protocol that stops the bleed.
Eating Through Immunotherapy: What's Different and Why It Matters
Immunotherapy side effects create a different nutritional landscape than chemotherapy — and most patients aren't prepared for it.
Retatrutide: What the Phase 2 Data Actually Shows
24.2% mean body weight reduction at 48 weeks. The triple agonist data is extraordinary — and the clinical implications are significant.
The Anti-Inflammatory Plate: A Blueprint for Metabolic Health
How to structure your meals to reduce chronic inflammation, support metabolic function, and build lasting dietary habits grounded in evidence.